Document Detail


Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C.
MedLine Citation:
PMID:  20832085     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: We retrospectively evaluated our results with the Shelhigh biological conduit model NR-2000C (Shelhigh, Inc, Milburn, NJ).
METHODS: From November 1998 through December 2007, 175 patients with a mean age of 71.1 ± 7.4 years underwent aortic root replacement with a Shelhigh biological conduit. Indication for surgery was aneurysmal disease of the aorta in 120 (68.6%) patients, aortic valve endocarditis in 20 (11.4%), acute type A aortic dissection in 11 (6.3%), and other in 24 (13.7%) patients.
RESULTS: Overall hospital mortality was 13.7% (n = 24; 95% confidence limits, 9.0%-19.7%). Cause of death was cardiac failure in 12 patients, central neurologic damage in 5 patients, pulmonary in 3 patients, gastrointestinal ischemia in 2 patients, and aorta-related in 2 patients. Mean follow-up was 3.1 years (range 0.2-9.9 years). In total, 50 (33.1%) late deaths occurred; of these 7 were valve-related. The overall survival at 1 and 5 years is 77.6% ± 3.2% and 54.6% ± 4.6% respectively. Six (4.0%) patients required reoperation, either for endocarditis of the bioconduit (n = 5) or for false aneurysm (n = 1). Endocarditis of the bioconduit was reported in 11 (7.3%) patients, of whom 6 were treated nonoperatively and 5 required reoperation.
CONCLUSIONS: Midterm results of the implantation of the Shelhigh biological valved conduit are worrisome. The relatively high incidence of endocarditis of the Shelhigh BioConduit has forced us to look for other alternatives.
Authors:
Abdullah Kaya; Robin H Heijmen; J C Kelder; Marc A Schepens; Wim J Morshuis
Related Documents :
9825065 - Personal follow-up of 100 aortic valve replacement patients for 1081 patient years.
16279585 - Mitral valve replacement in children under 3 years of age.
21095325 - The early and midterm function of decellularized aortic valve allografts.
2980055 - The carpentier-edwards supra-annular porcine bioprosthesis: new generation low pressure...
2575985 - Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
1835965 - A combined intra- and extra-articular reconstruction using a carbon-dacron composite pr...
Publication Detail:
Type:  Journal Article     Date:  2010-09-15
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  141     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1157-62     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Affiliation:
Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid peripheral arterial cannulation for extracorporeal life support with unimpaired distal perfusi...
Next Document:  Major complications during negative pressure wound therapy in poststernotomy mediastinitis after car...